Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ) Latest Company News

Oct 11, 2026, 08:13 UTC
China’s National Medical Products Administration approved Jinghua Pharmaceutical’s clinical-trial application for Jidesheng Snake Medicine Tablets for herpes zoster on October 8, 2026.
Source:
- finance.sina.cn
Oct 8, 2026, 07:58 UTC
China’s National Medical Products Administration approved safinamide mesylate as an active pharmaceutical ingredient for Jinghua Pharmaceutical Group Nantong Co., a subsidiary of Jinghua Pharmaceutical.
Source:
- finance.sina.cn

002349.SZ